dermaPACE System
-
Biologics
SANUWAVE Announces Attendance and Exhibition at SAWC; Visit Us at Booth Number 108
SUWANEE, GA, April 10, 2018 (GLOBE NEWSWIRE) — SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that the company will exhibit…
Read More » -
Biologics
SANUWAVE Will Have Four Podium Presentations as New Clinical Research at EWMA in Poland in May 2018
SUWANEE, GA, March 27, 2018 (GLOBE NEWSWIRE) — SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that during its…
Read More » -
Biologics
DermaPace Technology Suggests Promising Outcomes of Acoustic Pressure Shockwave Treatment for Venous Leg Ulcers (VLU)
SUWANEE, GA, March 08, 2018 (GLOBE NEWSWIRE) — SANUWAVE Health, Inc. (OTCQB: SNWV), an emerging medical technology company focused on the development…
Read More » -
Hospitals
Sanuwave Receives FDA De Novo Decision to Immediately Market the Dermapace System for the Treatment of Diabetic Foot Ulcers in the U.S.
SUWANEE, GA, Jan. 02, 2018 (GLOBE NEWSWIRE) — SANUWAVE Health, Inc. (OTCQB: SNWV) has announced that the U.S. Food and Drug Administration…
Read More »